Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket

Published 07/10/2022, 12:49
Updated 07/10/2022, 13:40
© Reuters.  Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket

Gainers

  • InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares rose 42.3% to $11.36 in pre-market trading after jumping 83% on Thursday.
  • HEXO Corp. (NASDAQ: HEXO) rose 26.9% to $0.2719 in pre-market trading. Shares of HEXO traded higher by 17% on Thursday after President Biden issued a statement on marijuana reform, which mentioned pardoning 'all prior federal offenses of simple marijuana possession.'
  • Akanda Corp. (NASDAQ: AKAN) rose 20.8% to $0.50 in pre-market trading.
  • Plus Therapeutics, Inc. (NASDAQ: PSTV) rose 19.2% to $0.65 in pre-market trading. JonesTrading initiated coverage on Plus Therapeutics with a Buy rating and announced a price target of $5.
  • Akerna Corp. (NASDAQ: KERN) rose 18.2% to $0.1350 in pre-market trading. The company’s stock jumped around 18% on Thursday after President Biden issued a statement on marijuana reform, which mentioned pardoning 'all prior federal offenses of simple marijuana possession.'
  • Inventiva S.A. (NASDAQ: IVA) rose 15.8% to $4.82 in pre-market trading after gaining around 10% on Thursday.
  • Bright Green Corporation (NASDAQ: BGXX) rose 15.2% to $1.14 in pre-market trading. Bright Green recently reported close of transaction with Alterola Biotech.
  • Ambac Financial Group, Inc (NASDAQ: AMBC) rose 13.4% to $14.51 in pre-market trading. Ambac settled RMBS litigations against Bank Of America for $1.84 billion.
  • Innovative Eyewear, Inc. (NASDAQ: LUCY) rose 12.7% to $1.84 in pre-market trading. The company released October investor presentation on Thursday.
  • The Valens Company Inc. (NASDAQ: VLNS) rose 12.6% to $1.00 in pre-market trading. The Valens Company is expected to issue its Q3 financial results on Thursday, October 13, 2022, before market open.
  • Locafy Limited (NASDAQ: LCFY) rose 11.5% to $0.63 in pre-market trading after jumping around 13% on Thursday. Locafy recently announced it officially launched Brand Boost.
  • Aehr Test Systems (NASDAQ: AEHR) rose 11.1% to $15.41 in pre-market trading as the company posted better-than-expected results for its first quarter on Thursday.
  • cbdMD, Inc. (NASDAQ: YCBD) rose 10.7% to $0.31 in pre-market trading after surging 14% on Thursday.
  • Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) rose 10.5% to $0.6490 in pre-market trading. Cyclerion shares dropped 37% on Thursday after the company announced a mitochondrial disease-focused strategy.
  • Payoneer Global Inc. (NASDAQ: PAYO) rose 8.9% to $7.69 in pre-market trading. Payoneer Global will replace Lantheus Holdings in the S&P SmallCap 600 effective on Wednesday, October 12.
  • Atlas Corp. (NYSE: ATCO) rose 7.3% to $15.07 in pre-market trading. Poseidon Acquisition continued discussions to acquire all common shares of Atlas not controlled by consortium members for $15.50 per share in cash.
  • DraftKings Inc. (NASDAQ: DKNG) rose 7% to $17.17 in pre-market trading on the buzz surrounding a large partnership with Walt Disney’s ESPN.
  • Credit Suisse (SIX:CSGN) Group AG (NYSE: CS) rose 6.3% to $4.56 in pre-market trading after reports said the company was planning to buy back $3 billion of its debt as part of its plans to streamline following questions about its financial health.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Losers

  • Avenue Therapeutics, Inc. (NASDAQ: ATXI) fell 59% to $2.58 in pre-market trading. Avenue Therapeutics priced its 3.6 million unit offering at $3.30 per unit.
  • Argo Blockchain plc (NASDAQ: ARBK) fell 20.4% to $3.32 in pre-market trading. Argo intends to raise around £24 million ($27 million) via proposed subscription with a strategic investor.
  • Green Giant Inc. (NASDAQ: GGE) shares fell 19.2% to $1.52 in pre-market trading after jumping 161% on Thursday.
  • Statera Biopharma, Inc. (NASDAQ: STAB) fell 19% to $0.1850 in pre-market trading. Statera Biopharma said it has completed Fiscal 2021 audit and filed Form 10-K.
  • PureTech Health plc (NASDAQ: PRTC) fell 18.2% to $25.36 in pre-market trading. Puretech Health confirmed that it has exchanged indicative, non-binding proposals with Nektar Therapeutics regarding a possible combination.
  • Bone Biologics Corporation (NASDAQ: BBLG) shares fell 17.7% to $0.7403 in pre-market trading after declining around 12% on Thursday.
  • Pineapple Energy Inc. (NASDAQ: PEGY) fell 16.9% to $3.78 in pre-market trading after jumping around 65% on Thursday.
  • Atlis Motor Vehicles, Inc. (NASDAQ: AMV) shares fell 12.1% to $21.50 in pre-market trading after jumping 95% on Thursday.
  • FingerMotion, Inc. (NASDAQ: FNGR) fell 12.1% to $6.31 in pre-market trading after declining 19% on Thursday.
  • iMedia Brands, Inc. (NASDAQ: IMBI) fell 11.7% to $0.5917 in pre-market trading after dipping 10% on Thursday.
  • Agrify Corporation (NASDAQ: AGFY) shares fell 11.1% to $0.48 in pre-market trading. Agrify issued statement refuting lawsuit from defaulted customer Bud & Mary's Cultivation.
  • Levi Strauss & Co (NYSE: NYSE:LEVI) fell 5.3% to $15.08 in pre-market trading. Levi Strauss reported upbeat earnings for its third quarter on Thursday, but lowered its full-year profit view.
  • Advanced Micro Devices, Inc. (NASDAQ: NASDAQ:AMD) fell 5.3% to $64.28 in pre-market trading after the company lowered its sales guidance for the third quarter.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.